Acuity Brands, Inc. (NYSE: AYI) announced today it has entered into a private label supply agreement with UV Angel to enable Acuity Brands to purchase and resell the UV Angel Clean Air™ pathogen control system, as well as pursue joint developments of UV light disinfection products. The UV Angel Clean Air system integrates UV-C light technology into a ceiling-mount luminaire that offers an unobtrusive environmental treatment system that uses concealed ultraviolet light to safely treat air automatically and continuously to neutralize pathogens. The agreement provides Acuity Brands with limited exclusivity for certain private label products throughout North America.
“Our agreement with UV Angel builds upon Acuity Brands’ offering of an industry-leading selection of advanced technologies and approaches to meet the diverse disinfection and budget requirements of our customers,” said Gary Trott, Vice President of Technology Commercialization, Acuity Brands Lighting.
Applications for the UV Angel Clean Air system include any commercial indoor space where a reduction in harmful pathogens is desired or required. Examples of indoor spaces that could benefit from the UV Angel Clean Air system include health care, education, commercial office, hospitality, retail, manufacturing (e.g., food processing plants), and general public and customer indoor gathering spaces at airports, restaurants and theatres.
“It is exciting for us to partner with a leading company committed to health and safety like Acuity Brands,” said Paul Byrne, Vice President of Product for UV Angel. “This aligns with our mission to provide advanced life-changing pathogen control technologies worldwide. UV Angel Clean Air is another example of our commitment to this mission, and a result of years of advanced research and development in ultraviolet light and IoT-enabled technologies to create a modern and effective air treatment system with a proven efficacy.”
Acuity Brands expects to have products with the UV Angel Clean Air pathogen control system in stock within the first calendar quarter of 2021. For more information about the UV light disinfection solutions offered by Acuity Brands, please visit UV Disinfection Technology.
*Any references to “disinfection” are referring generally to the reduction of pathogenic bioburden and are not intended to refer to any specific definition of the term as may be used for other purposes by the U.S. Food and Drug Administration or the U.S. Environmental Protection Agency.
About UV Angel
UV Angel was founded with a mission to create safer environments around the world through the development of life-changing pathogen control technologies. The company uses years of advanced research and the latest technology developments in ultraviolet light, to help make the environments around us cleaner and safer by reducing harmful pathogens. Fully automated, patented and proven safe, the company’s UV-C technology can be used in occupied spaces to clean the surfaces we touch and the air we breathe. UV Angel’s technology is complemented by a proprietary data analytics platform that delivers critical insights and strategic advantages to leaders in healthcare, food service, retail, corporate, education and many more industries. Learn more uvangel.com.
About Acuity Brands
Acuity Brands, Inc. (NYSE: AYI) is a market-leading industrial technology company. We design, manufacture, and bring to market innovative products and services that make the world more brilliant, productive, and connected including building management systems, lighting, lighting controls, and location-aware applications. Based in Atlanta, Georgia, with operations across North America, Europe, and Asia, we are powered by approximately 11,000 dedicated and talented associates. Visit us at www.acuitybrands.com.
All trademarks referenced are property of their respective owners.
This release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that may be considered forward-looking include statements incorporating terms such as “expects,” “believes,” “intends,” “estimates”, “forecasts,” “anticipates,” “could,” “may,” “should”, “suggests,” “remain,” and similar terms that relate to future events, performance, or results of the Company and specifically include statements made in this press release regarding UV Partners, Inc., (dba UV Angel) and its products’ ability to reduce harmful pathogens, (b) our ability to expand our portfolio of UV disinfection products and work together with UV Angel to develop new UV lighting products, as well as (c) our ability to meet our customers’ evolving disinfection needs and help promote wellbeing in a variety of indoor locations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the historical experience of the Company and management’s present expectations or projections. The risks and uncertainties that could cause actual results to differ materially from those expressed in our forward-looking statements are more fully described in the Company’s SEC filings including risks discussed in Part I, “Item 1a. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended August 31, 2020, and Part II, “Item 1a. Risk Factors” in the Company’s Form 10-Q for the quarterly period ended November 30, 2020. The discussion of those risks is specifically incorporated herein by reference. Management believes these forward-looking statements are reasonable; however, undue reliance should not be placed on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and management undertakes no obligation to update publicly any of them considering new information or future events